These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9413429)

  • 21. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.
    Yahya F; Jasmin R; Ng CT; Cheah TE; Sockalingam S
    Int J Rheum Dis; 2013 Dec; 16(6):724-30. PubMed ID: 24119227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug therapy: immunosuppressive agents (second of two parts).
    Kaplan SR; Calabresi P
    N Engl J Med; 1973 Dec; 289(23):1234-6. PubMed ID: 4594161
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of systemic lupus erythematosus with antimetabolites. Relations between the clinical course and immunological reactions].
    Cruchaud A; Pometta D; Rousso C
    Helv Med Acta Suppl; 1967 May; 47():141-2. PubMed ID: 5315493
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinicopathological study of the WHO classification in childhood lupus nephritis.
    Zappitelli M; Duffy C; Bernard C; Scuccimarri R; Watanabe Duffy K; Kagan R; Gupta IR
    Pediatr Nephrol; 2004 May; 19(5):503-10. PubMed ID: 15022106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature.
    Conti F; Ceccarelli F; Perricone C; Massaro L; Cipriano E; Pacucci VA; Truglia S; Miranda F; Morello F; Alessandri C; Spinelli FR; Valesini G
    Immunol Res; 2014 Dec; 60(2-3):270-6. PubMed ID: 25468307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemotherapy of leukemia--application of anti-leukemic agents].
    Kimura I; Kitajima K
    Nihon Rinsho; 1969 Jun; 27(6):1671-8. PubMed ID: 5816834
    [No Abstract]   [Full Text] [Related]  

  • 27. Systemic lupus erythematosus XII: Cytotoxic therapy and pheresis.
    Stevens MB
    Md State Med J; 1984 Jul; 33(7):538-40. PubMed ID: 6381919
    [No Abstract]   [Full Text] [Related]  

  • 28. [Indications for immunosuppressive treatment in kidney diseases of children].
    Wojnarowski M; Wyszyńska T
    Pediatr Pol; 1969 May; 44(5):525-30. PubMed ID: 4183009
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antineoplastic chemotherapy in gynecology; some generalizations].
    Wolff JP
    Gynecol Prat; 1967; 18(6):525-30. PubMed ID: 4987387
    [No Abstract]   [Full Text] [Related]  

  • 30. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.
    Fanouriakis A; Adamichou C; Koutsoviti S; Panopoulos S; Staveri C; Klagou A; Tsalapaki C; Pantazi L; Konsta S; Mavragani CP; Dimopoulou D; Ntali S; Katsikas G; Boki KA; Vassilopoulos D; Konstantopoulou P; Liossis SN; Elezoglou A; Tektonidou M; Sidiropoulos P; Erden A; Sfikakis PP; Bertsias G; Boumpas DT
    Semin Arthritis Rheum; 2018 Dec; 48(3):467-474. PubMed ID: 29555348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases.
    Naarendorp M; Kerr LD; Khan AS; Ornstein MH
    J Rheumatol; 1999 Oct; 26(10):2257-60. PubMed ID: 10529151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR; Sato EI
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.
    Garcia-Carrasco M; Mendoza-Pinto C; Sandoval-Cruz M; Soto-Vega E; Beltran-Castillo A; Jimenez-Hernandez M; Graillet D; Gonzalez L; Rojas-Rodriguez J; Pineda-Almazana A; Zamudio-Huerta L; Lopez-Colombo A
    Lupus; 2010 Feb; 19(2):213-9. PubMed ID: 19965944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combination antimetabolite-alkylating agent-vinblastine in the treatment of advanced breast cancer].
    Pipino G; Germiniani R; Lavorato F
    Minerva Med; 1977 Mar; 68(13):835-7. PubMed ID: 321990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-agent therapy for Hodgkin's disease.
    Carter SK; Livingston RB
    Arch Intern Med; 1973 Mar; 131(3):377-87. PubMed ID: 4631683
    [No Abstract]   [Full Text] [Related]  

  • 36. Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-up.
    Liao YN; Liu CS; Tsai TR; Hung YC; Chang SJ; Lin HL; Chen YC; Lai HM; Yu SF; Chen CJ
    Kaohsiung J Med Sci; 2011 Jul; 27(7):251-7. PubMed ID: 21757141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of electroconvulsive therapy in an adolescent with systemic lupus erythematosus for management of depression.
    Grover S; Aarya KR; Sharma A
    J ECT; 2013 Sep; 29(3):e50-1. PubMed ID: 23965611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide.
    Benenson E; Fries JW; Heilig B; Pollok M; Rubbert A
    Clin Rheumatol; 2005 Jun; 24(3):251-7. PubMed ID: 15940558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of add-on tacrolimus for minor flare in patients with systemic lupus erythematosus: a retrospective study.
    Watanabe H; Yamanaka R; Sada KE; Zeggar S; Katsuyama E; Katsuyama T; Narazaki MT; Tatebe NT; Sugiyama K; Watanabe KS; Wakabayashi H; Kawabata T; Wada J; Makino H
    Lupus; 2016 Jan; 25(1):54-60. PubMed ID: 26296361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen.
    Ezeonyeji AN; Isenberg DA
    Rheumatology (Oxford); 2012 Mar; 51(3):476-81. PubMed ID: 22096015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.